Tensive

27/11/2025

Margherita Tamplenizza, Co-founder e Chief Quality Regulatory Affairs Officer di Tensive, e Diana Saraceni, Managing Partner di Panakès Partners e membro del Board di Tensive, saranno presenti ad “INVESTING FOR LIFE – Dall’Italia all’Europa i finanziamenti per la ricerca e l’innovazione nelle scienze della vita”, evento promosso da Cluster Nazionale Scienze della Vita ALISEI e Cluster lombardo scienze della vita che si terrà il 2–3 dicembre 2025.

📌 2 dicembre, 14:50–15:30
Margherita Tamplenizza parteciperà, in qualità di relatrice, nella tavola rotonda “Horizon: potenziare l’accesso dell’Italia ai finanziamenti UE”.

📌 2 dicembre, 17:10–17:50
Diana Saraceni farà parte del panel “Innovare per la vita: strumenti e strategie nazionali per la ricerca, l’innovazione e lo sviluppo”.

Per maggiori informazioni: clusteralisei.it/eventi/investing-for-life

08/10/2025

It’s important during hashtag to raise awareness of the goals we are still striving to reach. Did you know that compared with mastectomy, more than twice as many patients undergo lumpectomy every year – and three-quarters of them receive no reconstruction care at all?

It’s not because there’s no need: up to 40% of patients report asymmetry or disfigurement that requires correction after lumpectomy, while many more simply tolerate these changes, even though they can be psychologically devastating. Rather, the reason these patients are untreated is that there simply is no viable reconstruction option for them.

That’s why Tensive is developing REGENERA™ and SOFTAG™ bioresorbable implants as minimally invasive, one-step solutions that are appropriate for any lumpectomy. Our implants use a soft synthetic scaffold that resembles a very fine sponge, whose structure facilitates regrowth of blood vessels and soft tissue, and which is gradually absorbed by the body. The devices are implanted during the lumpectomy procedure.

Imaging data from a first-in-human study and interim results from our ongoing pivotal trial confirm that breast restoration with REGENERA™ is safe and results in natural tissue that preserves the original shape and feel of the breast, yet is clearly differentiated from surrounding tissues on imaging.

SOFTAG™ uses the same bioresorbable, customizable scaffold as a tumor resection marker to support precision delivery of radiotherapy to the tumor bed.

Visit our website at www.tensive.com to learn more about our work to bring REGENERA™ and SOFTAG™ to approval for women undergoing lumpectomy.

24/09/2025

Yesterday, Sanjay Kakkar, CEO of Tensive, took part in the Confindustria Dispositivi Medici event in Milan, held as part of the Lombardy stop of the roadshow “Insieme per un Paese in Salute” — a six-stage journey organized in collaboration with Assolombarda and Confindustria with media partnership of L’Economia del Corriere della Sera, to celebrate the Association’s 40th anniversary

Sanjay presented the Tensive model as a virtuous example of life science innovation in Lombardy, highlighting how scientific research and entrepreneurship can drive real impact in healthcare.

12/09/2025

We’re excited to share that Tensive will be participating in the upcoming Confindustria Dispositivi Medici event, where Sanjay Kakkar, CEO of Tensive, will present the company and highlight its latest, tremendous progress in the field of breast reconstruction.

See you on September 23rd at the Assolombarda headquarters in Milan!

“Dispositivi medici: innovazione e imprese per la Sanità del futuro”, il programma della quarta tappa del roadshow “Insieme per un Paese in Salute”, che celebra i nostri 40 anni con l’obiettivo di valorizzare il comparto dei , un settore che è indispensabile salvaguardare e di cui è necessario favorire lo sviluppo a beneficio dell'economia italiana e della salute delle persone.

L’appuntamento a Milano sarà l’occasione per un focus sull’unicità del tessuto industriale lombardo e per promuovere un confronto costruttivo tra imprese, istituzioni, stakeholder e mondo della ricerca.

L’evento è realizzato in collaborazione con , Lombardia e con la media partnership del della sera. La partecipazione all’evento è gratuita e aperta al pubblico fino ad esaurimento posti.

Iscriviti: https://www.confindustriadm.it/calendario/dispositivi-medici-innovazione-e-imprese-per-la-sanita-del-futuro/

Intervengono:

Giuseppe Pasini, Confindustria Lombardia
Fabio Faltoni, Confindustria Dispositivi Medici
Valeria Glorioso, Confindustria Dispositivi Medici
Vittoria Ganassini, Corporate
Sanjay Kakkar, Tensive
Luca Ravagnan, Wise
Claudia Pingue, Fondo Technology Transfer di CDP Venture Capital
Roberto Tiezzi, Università degli Studi di Milano
Gianluca Vago, Cluster lombardo scienze della vita
Guido Beccagutti, Confindustria Dispositivi Medici
Federico Eichberg, Ministro delle Imprese e del Made in Italy
Alessandro Fermi, Regione Lombardia
Mario Melazzini, Regione Lombardia
Francesco Saverio Mennini, Ministero della Salute
Letizia Moratti, European Parliament
Marco Alparone, Regione Lombardia

Modera: Alessandra Puato, giornalista Corriere della Sera

📌 23 settembre | Milano

Delegazione di Confindustria presso l’Unione europea, Confindustria Emilia-Romagna, Confindustria Toscana Sud

12/09/2025

Tensive is pleased to announce new data confirming the potential of its REGENERA™ / SOFTAG™ candidate device to transform post-cancer breast reconstruction.

Here are the highlights we found:

• Strong safety profile and growing performance benefits of the device in clinical data from two ongoing trials in patients undergoing lumpectomy.
• High levels of patient and surgeon satisfaction in an interim analysis in our pivotal trial, which met primary safety and secondary performance objectives.
• The device was supportive in identifying the tumor bed, enabling the guiding of radiotherapy, according to an interim analysis of a separate cohort.
• Durable satisfaction with the device following lumpectomy reconstruction in three-year follow-up results in our first-in-human study.

Of the 2.1 million lumpectomies performed worldwide each year, 1.6 million are not reconstructed, because of a lack of viable options. Tensive is developing its REGENERA™ / SOFTAG™ candidate device to fill that substantial unmet medical need.

REGENERA™ / SOFTAG™ is gradually absorbed by the body, enabling the patient’s own healthy tissue to regrow. The result is restoration composed of natural tissue that preserves the original shape and feel of the patient’s breast shape and feel.

In addition, the implant is clearly differentiated from surrounding tissue on diagnostic imaging, supporting more targeted delivery of radiotherapy.

To read more about our solutions, go to www.tensive.com
For a link to our press release, please click on https://www.tensive.com/tensive-provides-positive-clinical-updates-highlighting-potential-of-regenera-softag-device-to-transform-post-cancer-breast-reconstruction/

30/01/2025

We are thrilled to announce our €14M Series A funding round led by Panakès Partners SGR to transform breast reconstruction following lumpectomy.

This milestone marks a transformative step forward in our mission to revolutionize breast reconstruction and augmentation through our innovative bio-absorbable implant technology, creating new opportunities to advance women’s health and breast care.

We are enthusiastic to welcome the support of Panakès Partners, the EIC Fund, and other esteemed investors who share our vision of improving the quality of life for breast cancer survivors worldwide.

We are also excited to welcome Dr. Sanjay Kakkar as our new CEO, bringing invaluable leadership and experience to drive Tensive’s growth and expansion.

This achievement brings us closer to making a lasting impact, reinforcing our commitment to restoring confidence and femininity, and improving the quality of life for breast cancer patients.

Read more about our Series A round here: https://www.tensivemed.com/tensive-raises-14m-series-a-financing-round/

Tensive raises €14,000,000 Series A Financing Round led by Panakès Partners SGR to transform breast reconstruction following lumpectomy.

06/11/2024

Want to join a fast-growing company making a real impact? At Tensive, we’re on a mission to improve the quality of life for breast cancer patients after lumpectomy.

We’re looking for a passionate Quality Assurance Specialist to help bring our innovative solution to the market.

Check out the role here: https://www.tensivemed.com/it/careers/quality-assurance-specialist/

Let’s transform lives together!

We are looking for a Regulatory Affairs Specialist (RAS) to work closely with our Quality Assurance & Regulatory Affairs (QA&RA) team in managing the regulatory affairs activities and executing our Quality Management System (QMS) in accordance with the requirements of ISO 13485:2016.

21/10/2024

In honor of Breast Cancer Awareness Month, we are excited to announce a significant milestone in our mission to support patients affected by breast cancer by improving their quality of life. Tensive has launched a pivotal clinical trial to assess the safety and performance of REGENERA in patients undergoing reconstructive surgery following lumpectomy for malignant breast lesions.

This study is a critical step in advancing innovative solutions for breast cancer patients, and we are committed to making a positive impact in their recovery journey.

To learn more, read our press release here: https://www.tensivemed.com/tensive-s-r-l-announces-multi-center-pivotal-clinical-trial-for-regenera-implant-in-post-lumpectomy-breast-reconstruction/


IEO Istituto Europeo di Oncologia

Tensive S.r.l. announces the launch of a groundbreaking multi-center clinical trial that represents a significant advancement in the post-lumpectomy breast reconstruction field.

27/08/2024

We’re excited to announce a new opportunity at Tensive! We’re looking for an Equipment Specialist to join our innovative team. If you’re passionate about medical devices and want to be part of a dynamic, growing company, we’d love to hear from you.

For more details and to apply, visit: https://www.tensivemed.com/careers/equipment-specialist/

Join us in advancing healthcare technology!

Tensive is looking for an Equipment Specialist who will be responsible for managing all production and R&D equipments.

04/05/2024

We're thrilled to announce an exciting opportunity to join our team as a Site Manager in Milan! If you're dedicated to quality and excited about working in a dynamic environment, this is the role for you. This position offers the chance to contribute to a noble mission.

Learn more and apply today: www.tensivemed.com/careers/site-manager-open/

Tensive is looking for a highly skilled Site Manager for its headquarters in Milan, Italy.

20/02/2024

Exciting opportunities!
Join our company as we're on the lookout to expand our Production team to drive excellence in our operations. Explore more on our career page and apply today!

https://www.tensivemed.com/careers/

Copyright TENSIVE s.r.l. © 2016-2024 All rights reserved | Via Timavo, 34 20124 Milan (Italy) | Reg. Imprese MI/C.F./VAT 08045870964 Privacy Policy - Cookie Policy

17/01/2023

We are excited to announce that we have been awarded blended finance consisting of a € 2.5 million grant and an additional € 6 million in equity investment by the European Innovation Council (EIC) Accelerator for our project REGENERA.

We couldn’t be prouder of this achievement and are grateful to our team and partners for all the efforts and dedication demonstrated throughout the years to make this success happens.

Tensive S.r.l., the medical technology company pioneering innovative solutions for reconstructivesurgery, announces that it is among the 78 winners of the prestigious EIC Accelerator program (October2022 cut-off). Tensive was awarded blended finance consisting of a € 2.5 million grant and an addit...